Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...
Read Full NewsExplore the evolving landscape of developmental and epileptic encephalopathies in adults, highlighting precision therapies and the need for accurate diagnoses.
Explore the transformative buzzwords in neurology for 2025, highlighting advancements in AI, gene therapy, personalized treatment, and neuroplasticity.
1.
Adaptive SABR-Used Hypofractionated Chemoradiation Showed Good Results in NSCLC.
2.
Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC
3.
Best foot forward—chemo care should include podiatry, say researchers
4.
Telemedicine services linked to reducing excess mortality
5.
Inner Thoughts of Leonard Bernstein, the "Maestro".
1.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
2.
Unveiling Tumor Immunity: Pan-Cancer Proteogenomics Characterization
3.
Cancer Immunotherapy: Advances, Guidelines, and Practical Tools for Modern Oncology Practice
4.
Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms
5.
An Introduction To The CA 15-3 Tumor Marker Test For Cancer Patients
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
2.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
4.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
5.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge